PET/MR成像评估头颈部恶性肿瘤治疗失败:基于颈部影像报告和数据系统的研究
该研究回顾性纳入46例头颈部恶性肿瘤治疗后行PET/MR检查的患者,由2名神经放射科医师分别基于单独MRI序列和PET/MR联合图像按颈部影像报告和数据系统(采用CT/PET-CT标准)评分。PET/MR评分与治疗失败强相关(原发灶、颈部淋巴结及联合部位P均<.001),ROC曲线下面积0.864-0.987(P<.001),读者间一致性κ=0.634。
要点
- PET/MR联合评分与治疗失败强相关,原发灶、颈部淋巴结及联合部位P均<.001。
- PET/MR评分诊断治疗失败的ROC曲线下面积范围为0.864-0.987(P<.001)。
- 2名读者间PET/MR评分一致性为κ=0.634(95%CI 0.605-0.663)。
核心结论
- 同时性PET/MR成像应用颈部影像报告和数据系统评分时,对头颈部恶性肿瘤治疗结局具有极好的判别性能,可能在对头颈部肿瘤的监测成像中发挥重要作用。
研究设计与样本
- 回顾性研究,纳入46例治疗后行PET/MR成像的患者,由2名神经放射科医师独立评分,分别基于单独诊断性MR序列和PET/MR联合图像,按颈部影像报告和数据系统(采用CT/PET-CT标准)评分;治疗失败以活检病理或启动新治疗确定。
诊断标准与关键数值
- PET/MR评分与治疗失败的单变量关联分析显示原发灶、颈部淋巴结及联合部位P均<.001;PET/MR评分预测治疗失败的ROC曲线下面积范围为0.864-0.987(P<.001);读者间一致性κ=0.634(95%CI 0.605-0.663)。
临床应用与阅片要点
- 作者认为,同时性PET/MR成像应用颈部影像报告和数据系统评分时,对头颈部恶性肿瘤治疗结局具有极好的判别性能,可能在对头颈部肿瘤的监测成像中发挥重要作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: PET/MR imaging is a relatively new hybrid technology that holds great promise for the evaluation of head and neck cancer. The aim of this study was to assess the performance of simultaneous PET/MR imaging versus MR imaging in the evaluation of posttreatment head and neck malignancies, as determined by its ability to predict locoregional recurrence or progression after imaging.
MATERIALS AND METHODS: The electronic medical records of patients who had posttreatment PET/MR imaging studies were reviewed, and after applying the exclusion criteria, we retrospectively included 46 studies. PET/MR imaging studies were independently reviewed by 2 neuroradiologists, who recorded scores based on the Neck Imaging Reporting and Data System (using CT/PET-CT criteria) for the diagnostic MR imaging sequences alone and the combined PET/MR imaging. Treatment failure was determined with either biopsy pathology or initiation of new treatment. Statistical analyses including univariate association, interobserver agreement, and receiver operating characteristic analysis were performed.
RESULTS: There was substantial interreader agreement among PET/MR imaging scores (κ = 0.634; 95% CI, 0.605-0.663). PET/MR imaging scores showed a strong association with treatment failure by univariate association analysis, with P < .001 for the primary site, neck lymph nodes, and combined sites. Receiver operating characteristic curves of PET/MR imaging scores versus treatment failure indicated statistically significant diagnostic accuracy (area under curve range, 0.864-0.987; P < .001).
CONCLUSIONS: Simultaneous PET/MR imaging has excellent discriminatory performance for treatment outcomes of head and neck malignancy when the Neck Imaging Reporting and Data System is applied. PET/MR imaging could play an important role in surveillance imaging for head and neck cancer.
引用
- Patel, Bridgham, Ciriello, et al. PET/MR Imaging in Evaluating Treatment Failure of Head and Neck Malignancies: A Neck Imaging Reporting and Data System-Based Study. AJNR Am J Neuroradiol. 2022. PMID: 35177543. doi:10.3174/ajnr.A7427
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。